type here...

CATEGORIES

Healthcare

LATEST

1...272829...76Page 28 of 76

TRENDING

EDITORS CHOICE

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Medika Life -
European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

How Republican Radicals Are Weaponizing Healthcare in America

Robert Turner, Founding Editor -
Seditious elements within the GOP are weaponizing healthcare as a tool to further their racist, white supremacy goals. They're even holding conferences to strategize.

Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

Medika Life -
Three studies report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.

Forever Medicated is the Future of Healthcare

Robert Turner, Founding Editor -
Greed is one of our most destructive traits and no one is more prone to fall prey to its grip than the shareholders of...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories